COVID-19 silver lining - Globally coordinated research into new treatments

May 8, 2020

At least one positive thing has come out of this COVID-19 crisis so far.   It is not so much that Australia is joining this collective fight to find treatments etc for this virus.


It is that globally , there has been far too little investment in research and development of new antibiotics and anti-bacterial treatments, as drug-resistance grows to current antibiotics. People like Jim O'Neill have been trying to raise global awareness of this problem - so that there can be more money focused collectively on this global problem. But the world has been too blasé, too complacent to put this effort in. And now maybe, COVID-19 has kindled the collective motivation to drive such global efforts with COVID-19 being the initial focus. So there can be a silver lining in a dark cloud.

  • With the world’s attention on COVID-19, I believe that now is the time to talk about another pandemic that’s been happening right under our noses: antimicrobial resistance (AMR).

  • The United Nations, the World Health Organization and even the World Bank recognize AMR as a public health and economic disaster waiting to happen. In 2016, United Kingdom economist Jim O’Neill and his team published a report stating that if we do not address the growing threat of AMR, by 2050 more people will die from drug-resistant infections than from cancer.





Please reload

Featured Posts

I'm busy working on my blog posts. Watch this space!

Please reload

Recent Posts
Please reload

Please reload

Search By Tags

I'm busy working on my blog posts. Watch this space!

Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Postal Address

PO Box 739

Kenmore, Queensland



T: 07 3202 6044

M: 0434 905 885